Session Information
-
WCLC 2021
2021 World Conference on Lung Cancer
Presentation Date(s):- September 8 - 14, 2021
- Total Presentations: 1107
All times listed are in Mountain Time MDT (UTC-6:00)
PL - Plenary
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
FP - Featured Posters
P - Posters
WS - Workshops
IS - Industry Symposium
MTE - Meet the Expert
BEDG - Brain Exchange Discussion Groups
September 8 Wed
Sep 8 Thursday
September 9 Thu
Sep 9 Friday
September 10 Fri
Sep 10 Saturday
September 11 Sat
Sep 11 Sunday
September 12 Sun
Sep 12 Monday
September 13 Mon
Sep 13 Tuesday
September 14 Tue
Sep 14
-
+
OA15 - Upcoming Molecular Targeted Agents for EGFR exon 20 Insertion and MET Skipping Mutation
- 18:45 - 19:45
- 9/12/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Oral
- Track: Novel Therapeutics and Targeted Therapies
- Moderators:Helena A Yu
-
+
OA15.01 - Mobocertinib in EGFR Exon 20 Insertion–Positive Metastatic NSCLC Patients With Disease Control on Prior EGFR TKI Therapy
18:45 - 18:55 | Presenter: Alexander Spira
- Abstract
Loading...
-
+
IS11 - Satellite CME Symposium by Medscape: Answers to Key Questions About Molecular Alterations Within NSCLC: How Do You Stack Up?
- 21:15 - 22:15
- 9/12/2021
- Location: Program Auditorium
- CME Accredited by Other Provider
- Type: Satellite CME Symposia
- Track: N.A.
-
+
IS11.01 - Introduction
21:15 - 21:15 | Presenter: Zofia Piotrowska
- Abstract
No abstract available for this presentation
-
+
IS11.02 - Key Questions for Practice: Optimizing the Diagnosis and Management of Patients with NSCLC and Molecular Alterations
21:15 - 21:15 | Presenter: Zofia Piotrowska, Joshua Sabari, Maureen Zakowski
- Abstract
No abstract available for this presentation
-
+
IS11.03 - Conclusions and Q&A
21:15 - 21:15 | Presenter: Zofia Piotrowska
- Abstract
No abstract available for this presentation
-
+
MA14 - Pathologic Patterns, Genomic Alterations and Targeted Therapies in NSCLC
- 18:45 - 19:45
- 9/13/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Mini Oral
- Track: Predictive Tumor Based Assays/ Biomarkers/ Pathology
-
+
MA14.07 - EGFR-Mutant NSCLC With de novo or Acquired Squamous Histology: Molecular Features and Clinical Outcomes
19:25 - 19:30 | Presenter: Catherine Belle Meador
- Abstract
Loading...
